FRESH-PEF79-en
A European prospective observational study to evaluate fracture outcomes, back pain, health-related quality of life, and compliance in patients with osteoporosis during and after treatment with Forsteo®
EXFOS
| Name |
|---|
| Croatia |
| Denmark |
| France |
| Greece |
| Italy |
| Norway |
| Slovenia |
| Sweden |
Primary objective: determine the incidence of clinical vertebral fractures and non-vertebral fragility fractures in patients treated with teriparatide for about 18 months and a post-treatment follow-up period of at least 18 months. Secondary objectives: observance, treatment switching and cessation, clinical evolution, occurrence of back pain, direct costs linked to fractures.
['Clinical data','Participant-reported health data']
Individuals
| Topic | Vocabulary | URI |
|---|---|---|
| Rheumatology | health theme | |
| cim-11 | XS65 | |
| Healthcare system determinants: Use of care | health determinant | |
| Healthcare system determinants | health determinant |
{
"level_sex_clusion_I": [
"Male",
"Female"
],
"level_age_clusion_I": [
"Young Adult (19 to 24 years)",
"Adult (25 to 44 years)",
"Middle Aged (45 to 64 years)",
"Aged (65 to 79 years)",
"Aged, 80 and over (80 years and more)"
],
"level_type_clusion_I": [
"Patients population"
],
"level_type_clusion_other": "",
"clusion_I": "",
"clusion_E": ""
}
| Name | Role |
|---|---|
| LILLY FRANCE | sponsor |
| Name |
|---|
| LILLY FRANCE |
| Agency name |
|---|
| CNIL |
['Through independent healthcare practitioners']
['Other']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2006 | 2012 |
Longitudinal or cohort study
Restricted access
FRESH-PEF79-en